Sunrest Lifescience IPO GMP

Sunrest Lifescience IPO GMP: Sunrest Lifescience Limited, a pharmaceutical company established in October 2017, is gearing up to launch its SME IPO on the NSE Emerge platform. With a total size of Rs 10.85 Crores, this IPO comprises a 100% fresh issue, meaning that the funds raised through this offering will be utilized for the company’s expansion and growth. Investors looking to participate in this IPO can apply from November 7 to November 9, 2023. Each share has a face value of Rs 10, and the fixed price for each share is Rs 84. It’s important to note that to apply for this SME IPO, you must purchase at least one lot size, which consists of a minimum of 1600 shares, or in multiples thereof.

Let’s delve into the concept of Grey Market Premium (GMP) and understand its implications for Sunrest Lifescience’s upcoming IPO.

"Exciting news! Stockesta is now on WhatsApp and Telegram Channels 🚀 Subscribe today | Stay updated with the latest IPO insights!" Follow on Whatsapp! and Join Telegram!

Sunrest Lifescience IPO GMP

As of November 20, 2023, the Grey Market Premium (GMP) for Sunrest Lifescience’s IPO stands at Rs 5. This means that the unofficial market sentiment surrounding the IPO suggests that the listing price may be close to the IPO price of Rs 84 per share. [Last Updated: 20-Nov-2023; 09:30]

GMP DateIPO PriceGMPSub2 Sauda RateEstimated Listing Price
20-11-2023₹84₹56100₹89 (5.95%)
19-11-2023₹84₹56100₹89 (5.95%)
18-11-2023₹84₹56100₹89 (5.95%)
17-11-2023₹84₹56100₹89 (5.95%)
16-11-2023₹84₹56100₹89 (5.95%)
15-11-2023₹84₹1518200₹99 (17.86%)
14-11-2023₹84₹1518200₹99 (17.86%)
13-11-2023₹84₹1518200₹99 (17.86%)
12-11-2023₹84₹1518200₹99 (17.86%)
11-11-2023₹84₹1518200₹99 (17.86%)
10-11-2023₹84₹1518200₹99 (17.86%)
09-11-2023₹84₹1518200₹99 (17.86%)
08-11-2023₹84₹1720700₹101 (20.24%)
07-11-2023₹84₹2226800₹106 (26.19%)
06-11-2023₹84₹1315800₹97 (15.48%)
05-11-2023₹84₹1315800₹97 (15.48%)
04-11-2023₹84₹78500₹91 (8.33%)
03-11-2023₹84₹78500₹91 (8.33%)
02-11-2023₹84₹0₹84 (0%)
01-11-2023₹84₹0₹84 (0%)

Sunrest Lifescience IPO Grey Market Premium (GMP)

The Grey Market Premium (GMP) is the price at which an IPO is traded in an unofficial, unregulated grey market before its official listing on a stock exchange. The GMP essentially reflects the market’s expectations about how the IPO will perform on the day of listing. A positive GMP indicates that the IPO may list at a premium, while a negative GMP suggests that the IPO might list at a discount.

However, it’s crucial to understand that the GMP is not a guaranteed predictor of the listing price. It’s highly speculative and can be subject to significant volatility. Relying solely on GMP to make investment decisions can be risky. Potential investors should consider various factors and conduct thorough research before deciding whether to invest in Sunrest Lifescience’s SME IPO.

About Sunrest Lifescience

Sunrest Lifescience Limited, established in October 2017, operates in the pharmaceutical industry, primarily focusing on the distribution of generic over-the-counter (OTC) pharmaceuticals in the domestic market. The company offers a wide range of pharmaceutical products, sourced from third-party vendors. Its distribution network spans several Indian states, including Maharashtra, Gujarat, Madhya Pradesh, Orissa, and Rajasthan. Sunrest Lifescience markets these products under its own branded and registered products, which encompass capsules, tablets, syrups, ointments, gels, mouthwashes, solutions, suspensions, dry powders, and toothpaste.

The product portfolio covers a diverse array of pharmaceutical categories, such as antibacterial, antidiarrheal, antifungal, antidiabetic, dental, antiprotozoal, antihistamine, antihypertensive, cosmetic, antiparasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory products. With 18 registered trademarks for 32 products, the company has established a solid presence in the pharmaceutical market.

Sunrest Lifescience’s products are distributed to specialty retailers and wholesalers, eventually making their way to pharmacies, drugstores, hospitals, and other healthcare facilities. The company operates with support from group companies and various third-party manufacturers, relying on contract manufacturing or contractual agreements to meet customer demand.

Sunrest Lifescience SME IPO Strengths

  • Experienced Promoters and Management Team: The company benefits from an experienced team of promoters and management, which is crucial for the success and growth of any business.
  • Wide Range of Products: Sunrest Lifescience offers a diverse product range, including various pharmaceutical categories, which positions the company well in a competitive market.
  • Efficient Marketing Team: The efficiency of the marketing team is a significant asset, as effective marketing and distribution are vital in the pharmaceutical industry.

Sunrest Lifescience IPO Dates

Here are the key dates for Sunrest Lifescience SME IPO:

  • SME IPO Open Date: November 7, 2023
  • SME IPO Close Date: November 9, 2023
  • Basis of Allotment Finalization Date: November 15, 2023
  • Refunds Initiation Date: November 16, 2023
  • Credit of Shares to Demat Account: November 17, 2023
  • SME IPO Listing Date: November 20, 2023

Please note that these dates are tentative and subject to change.

While GMP can provide insights into market sentiment, it’s important for investors to consider various factors and conduct thorough due diligence before making investment decisions. Sunrest Lifescience’s strong product portfolio and experienced management team position it favorably in the pharmaceutical industry, making it an IPO worth keeping an eye on for potential investors.

"Exciting news! Stockesta is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest IPO insights!" Click here!

👉 IPO GMP || IPO News || IPO Details || IPO Review || Join Whatsapp Channel and read news related to IPO on Stockesta.com.
Disclaimer: The information provided on this website is for informational purposes only and should not be construed as financial or investment advice. Users are advised to do their own research and consult a qualified financial advisor before making any investment decisions.
What is an IPO?- Why Companies Go Public